Douglas M. Okamoto

The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and Epoetin

Anatole Besarab, W. Kline Bolton, Joan C. Egrie et al. · New England Journal of Medicine · 1998 · 1.9K citations · Full text

Medicine, Nephrology, Pharmacotherapy +16

Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers

Richard B. Stead, John S. Lambert, Dawie Wessels et al. · Blood · 2006 · 110 citations

Medicine, Hematology, Pharmacology +6

Intravenous versus subcutaneous dosing of Epoetin alfa in hemodialysis patients

Joseph W. Eschbach, J. Michael Lazarus, John C. Van Stone et al. · American Journal of Kidney Diseases · 1995 · 68 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Hematocrit stability following intravenous versus subcutaneous administration of epoetin alfa to dialysis patients: a post hoc analysis.

David A. Goodkin, Luis F. Gimenez, Stanley E. Gräber et al. · PubMed · 1999 · 16 citations

Medicine, Hematology, Pharmacology +13